The niche of hepatic cancer stem cell and cancer recurrence

Medical Hypotheses

Volumn 80, Issue 5, 2013, Pages 666-668

  Dong, Han hua ^a   Xiang, Shuai ^a   Liang, Hui fang ^a   Li, Chang hai ^a   Zhang, Zhi wei ^a   Chen, Xiao ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 6; KALININ; LAMININ; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STEM CELL; CANCER SURGERY; CELL ADHESION; CELL DIFFERENTIATION; CIRCULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; KUPFFER CELL; LIVER CANCER; LIVER FIBROSIS; LIVER RESECTION; MYOFIBROBLAST; STELLATE CELL; TISSUE REGENERATION; TUMOR MICROENVIRONMENT;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; STEM CELL NICHE;

EID: 84875617868     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.01.021     Document Type: Article

References (25)

1. Villanueva A., Minguez B., Forner A., Reig M., Llovet J.M. Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy. Annu Rev Med 2010, 61:317-328.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96.
3. Fan S.T., Mau Lo C., Poon R.T., Yeung C., Leung Liu C., Yuen W.K., et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 2011, 253(4):745-758.
4. Duvoux C., Roudot-Thoraval F., Decaens T., Pessione F., Badran H., Wolf P., et al. Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology 2012.
5. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414(6859):105-111.
6. Fan S.T., Yang Z.F., Ho D.W., Ng M.N., Yu W.C., Wong J. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Ann Surg 2011, 254(4):569-576.
7. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4(1-2):7-25.
8. Li L., Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005, 21:605-631.
9. Reagan M.R., Kaplan D.L. Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems. Stem Cells 2011, 29(6):920-927.
10. Yoo B.K., Emdad L., Su Z.Z., Villanueva A., Chiang D.Y., Mukhopadhyay N.D., et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009, 119(3):465-477.
11. Nakamura T., Sakai K., Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol 2011, 26(Suppl 1):188-202.
12. Sokolovic A., Sokolovic M., Boers W., Elferink R.P., Bosma P.J. Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells. Fibrogenesis Tissue Repair 2010, 3:3.
13. Amann T., Bataille F., Spruss T., Muhlbauer M., Gabele E., Scholmerich J., et al. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 2009, 100(4):646-653.
14. Zhang W., Chen X.P., Zhang W.G., Zhang F., Xiang S., Dong H.H., et al. Hepatic non-parenchymal cells and extracellular matrix participate in oval cell-mediated liver regeneration. World J Gastroenterol 2009, 15(5):552-560.
15. Benedicto I., Molina-Jimenez F., Barreiro O., Maldonado-Rodriguez A., Prieto J., Moreno-Otero R., et al. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. Hepatology 2008, 48(4):1044-1053.
16. Ramaiah S.K., Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci 2008, 103(1):4-13.
17. Kim S.H., Turnbull J., Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 2011, 209(2):139-151.
18. Sanchez A., Alvarez A.M., Pagan R., Roncero C., Vilaro S., Benito M., et al. Fibronectin regulates morphology, cell organization and gene expression of rat fetal hepatocytes in primary culture. J Hepatol 2000, 32(2):242-250.
19. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14(2):163-176.
20. Dong H.H., Xiang S., Chen X.P., Liang H.F., Zhang W., Jing K., et al. The epithelial-mesenchymal transition promotes transdifferentiation of subcutaneously implanted hepatic oval cells into mesenchymal tumor tissue. Stem Cells Dev 2009, 18(9):1293-1298.
21. Deng H., Wang H.F., Gao Y.B., Jin X.L., Xiao J.C. Hepatic progenitor cell represents a transitioning cell population between liver epithelium and stroma. Med Hypotheses 2011, 76(6):809-812.
22. Fransvea E., Mazzocca A., Antonaci S., Giannelli G. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma. Hepatology 2009, 49(3):839-850.
23. Yang J.C., Teng C.F., Wu H.C., Tsai H.W., Chuang H.C., Tsai T.F., et al. Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology 2009, 49(6):1962-1971.
24. Lai J.P., Chien J.R., Moser D.R., Staub J.K., Aderca I., Montoya D.P., et al. HSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 2004, 126(1):231-248.
25. Neaud V., Faouzi S., Guirouilh J., Le Bail B., Balabaud C., Bioulac-Sage P., et al. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology 1997, 26(6):1458-1466.